Locoregional tumor burden and risk of mortality in metastatic breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Locoregional tumor burden and risk of mortality in metastatic breast cancer
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 6, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-05
DOI
10.1038/s41698-022-00265-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Association of Independent Prognostic Factors and Treatment Modality With Survival and Recurrence Outcomes in Breast Cancer
- (2020) Dat Nguyen et al. JAMA Network Open
- Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast Cancer
- (2020) Almir Bitencourt et al. JAMA Network Open
- Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up
- (2019) Sherry X. Yang et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chromatin regulators mediate anthracycline sensitivity in breast cancer
- (2019) Jose A. Seoane et al. NATURE MEDICINE
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of γH2AX at Diagnosis with Chemotherapy Outcome in Patients with Breast Cancer
- (2017) Sherry X. Yang et al. Theranostics
- Prognostic Value of Intrinsic Subtypes in Hormone Receptor–Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib
- (2016) Aleix Prat et al. JAMA Oncology
- Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
- (2015) D J A Lobbezoo et al. BRITISH JOURNAL OF CANCER
- Nodal Status and Clinical Outcomes in a Large Cohort of Patients With Triple-Negative Breast Cancer
- (2011) Leonel F. Hernandez-Aya et al. JOURNAL OF CLINICAL ONCOLOGY
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival differences among women with de novo stage IV and relapsed breast cancer
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Akt Phosphorylation at Ser473 Predicts Benefit of Paclitaxel Chemotherapy in Node-Positive Breast Cancer
- (2010) Sherry X. Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor size and survival in breast cancer—a reappraisal
- (2010) William D. Foulkes et al. Nature Reviews Clinical Oncology
- Prognostic Factors in Metastatic Breast Cancer: Successes and Challenges Toward Individualized Therapy
- (2008) Eleni Andreopoulou et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now